MTNB
Matinas Biopharma Hl
Description:
Matinas BioPharma Holdings, Inc. (MTNB) is a clinical-stage biopharmaceutical company based in Bedminster, New Jersey, dedicated to innovating and advancing its proprietary delivery technologies for therapeutics. The company primarily focuses on developing oral lipid-based formulations for a range of infectious diseases and chronic indications, aimed at improving treatment efficacy and patient compliance. With a robust pipeline of candidate products and strategic partnerships, Matinas BioPharma is positioned to address significant unmet medical needs in the biopharmaceutical landscape, making it an intriguing opportunity for institutional investors seeking exposure to the biotechnology sector.
Address:
1545 ROUTE 206 SOUTH, BEDMINSTER, NJ, UNITED STATES, 07921
Fiscal year end:
December
Market capitalization:
$10.8 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-95%
How much will you get:
$46
Prices dates:
30-09-2015: $41.00 and 30-09-2025: $1.89